Industry
2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

VCID: 37834
Profile

Corporate information


Registration country
United States
Investment activity status
Active investor

Funding rounds

N/A


Profile Country Notes
BioEnterprise United States

Current and past shareholders

Investor Round
BioEnterprise logo BioEnterprise
 N/A

Selected investments

Country Date Notes
Incuron
Developer of the innovative class of drug substance (curaxins) for oncological and autoimmune treatment diseases 		Russia 12 Jan 2010 N/A
Active

DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.